Brooklyn, NY, United States of America

Valery Kudryashov

This inventor holds 1 USPTO granted patent. Top assignee: Sloan-Kettering Institute for Cancer Research. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Valery Kudryashov. Retrieved from https://idiyas.com/inventor/valery-kudryashov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Valery Kudryashov: Innovator in Glycopeptide Conjugates

Introduction

Valery Kudryashov is a notable inventor based in Brooklyn, NY, recognized for his contributions to the field of glycoconjugates. His innovative work focuses on the synthesis and application of glycopeptides, which hold significant potential in cancer treatment.

Latest Patents

Kudryashov holds a patent for "Glycopeptide conjugates and uses thereof." This invention provides novel glycoconjugates, including glycopeptides, and outlines convergent methods for their synthesis. An exemplary approach detailed in the patent involves the synthesis of the mucin motif commonly found on epithelial tumor cell surfaces. The invention also includes compositions and methods for treating cancer using these glycoconjugates.

Career Highlights

Valery Kudryashov is affiliated with the Sloan-Kettering Institute for Cancer Research, where he continues to advance research in cancer therapies. His work has garnered attention for its innovative approach to addressing complex medical challenges.

Collaborations

Kudryashov has collaborated with esteemed colleagues, including Samuel J. Danishefsky and Dalibor Sames, contributing to a rich environment of scientific inquiry and innovation.

Conclusion

Valery Kudryashov's work in glycopeptide conjugates exemplifies the intersection of innovation and medical research, showcasing the potential for new treatments in cancer therapy. His contributions are paving the way for future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…